The Total Coronary Score, often referred to as the Agatston score, in a Coronary Calcium Scan is a critical quantitative measure that encapsulates the cumulative burden of calcified plaque within the coronary arteries. This score is derived from a computed tomography (CT) scan, specifically designed to detect calcium deposits in the coronary arteries, which are a hallmark of atherosclerotic coronary artery disease (CAD). The Agatston method, named after its inventor, Dr. Arthur Agatston, assigns a density factor to each segment of detectable calcification, and this factor is multiplied by the area of the calcification to generate a score for each lesion. These individual lesion scores are then summed to obtain the total coronary calcium score. The higher the score, the greater the extent of calcification and, consequently, the higher the risk of future cardiac events such as myocardial infarction. The Total Coronary Score stratifies patients into risk categories: a score of zero suggests a low risk of CAD, while scores above 400 indicate a high risk. This scoring system is particularly valuable in asymptomatic individuals with intermediate risk factors, as it aids in decision-making regarding the intensity of preventive therapies. It's important to note, however, that the Total Coronary Score reflects only the burden of calcified plaque and does not account for non-calcified plaque, which can also be significant in the pathophysiology of CAD. Thus, while this score is a powerful tool in the assessment and management of CAD risk, it should be considered alongside other clinical evaluations and risk factors to provide a comprehensive approach to cardiovascular care and prevention.
A stress hormone produced by the adrenal glands
The inactive or “storage form” of adrenal glucocorticoid
These cells help eliminate infected or abnormal cells. The count shows how many are circulating, not how effectively they respond to a threat. Read it with % Cytotoxic (CD8) T Cell, Total T-Helper (CD4) Cell, and CD4/CD8 Ratio.
Total Cytotoxic NK (Natural Killer) cells, identified by the CD16+ marker, represent a crucial component in the innate immune system, playing a significant role in the body's first line of defense against tumors and virally infected cells. NK cells, characterized by their expression of the CD16 surface marker, are involved in the direct killing of target cells without the need for prior sensitization, distinguishing them from other lymphocytes that require antigen presentation. They are pivotal in controlling early responses to infection and malignancy through the release of cytolytic granules that induce apoptosis in target cells. Moreover, CD16+ NK cells can mediate antibody-dependent cellular cytotoxicity (ADCC), a mechanism by which cells coated with antibodies are recognized and destroyed, further emphasizing their role in immune surveillance and therapy. The assessment of Total Cytotoxic NK cells in the Lymphocyte MAP panel provides critical data, aiding in the diagnosis and monitoring of immune disorders, evaluating the risk of autoimmune diseases, and tailoring personalized immunotherapy treatments. This analytical capability underscores the importance of understanding NK cell dynamics in clinical practice, enhancing the precision of immune health assessments and the development of targeted therapeutic strategies.
Estrogen and testosterone are created from DHEA.
Female hormone
Female hormone
Although estrogen is identified with females, it is also found in men.
The marker "Total Estrogen Load" in a FU Female FMV Urine Comprehensive Hormone Panel is a critical measure for assessing the overall estrogenic activity in a woman's body. This comprehensive assessment quantifies the cumulative levels of estrogens, including estrone (E1), estradiol (E2), and estriol (E3), over an entire menstrual cycle. Estrogens are key hormones in female reproductive health, influencing menstrual cycle regulation, fertility, and secondary sexual characteristics. In a clinical setting, analyzing the total estrogen load is vital for diagnosing and managing conditions such as estrogen dominance, where there is an imbalance between estrogen and progesterone levels, often leading to symptoms like irregular menstrual cycles, fibrocystic breasts, mood swings, and weight gain. Additionally, this marker is instrumental in evaluating the risk factors for estrogen-related conditions, such as certain types of breast and endometrial cancers. The urine comprehensive hormone panel offers a dynamic view of estrogen metabolism over time, as opposed to a single snapshot, providing a more nuanced understanding of hormonal balance or imbalance. Elevated total estrogen levels might indicate conditions like polycystic ovary syndrome (PCOS), ovarian tumors, or liver dysfunction affecting hormone metabolism, while low levels can be associated with issues such as ovarian insufficiency or hypopituitarism. The treatment approach for abnormal total estrogen load involves addressing the underlying cause, which could include lifestyle modifications, dietary changes, hormonal therapies, or management of associated health conditions. Personalized treatment plans aim to restore hormonal balance, alleviate symptoms, and reduce the risk of long-term complications associated with abnormal estrogen levels.
Female hormone
Fat Malabsorption
indicates maldigestion if elevated
Oxidative Stress Marker
Oxidative Stress Marker
The Total Immunoglobulin A (IgA) biomarker, included in the 1018 Celiac Profile - Serum by Genova Diagnostics, plays a critical role in accurately assessing celiac disease and gluten-related disorders. Total IgA is essential for evaluating immune system function and ensuring the reliability of celiac-specific antibody tests. What Is Total IgA? Immunoglobulin A (IgA) is an antibody produced by the immune system to protect mucosal surfaces, such as the gastrointestinal and respiratory tracts. It serves as a first line of defense against infections and dietary antigens, like gluten. Why Is Total IgA Important for Celiac Testing? The 1018 Celiac Profile measures antibodies like anti-tissue transglutaminase (tTG) and deamidated gliadin peptide (DGP), which are critical markers for detecting celiac disease. However, if a person has IgA deficiency (a common immune condition), these tests can yield false-negative results. Measuring Total IgA ensures: The immune system is producing sufficient IgA for accurate testing. Any deficiency is identified, prompting additional testing with IgG-based markers to avoid misdiagnosis. Key Facts About IgA Deficiency IgA deficiency is one of the most common primary immunodeficiencies, affecting 1 in 500 individuals. People with IgA deficiency are at higher risk for autoimmune conditions like celiac disease. When Total IgA levels are low, IgG-based testing is used to confirm or rule out gluten-related disorders. How Total IgA Supports the Celiac Profile By including Total IgA in the panel, the Genova Diagnostics test ensures: Test Accuracy: Proper interpretation of other celiac-specific biomarkers. Reliable Results: Reduced risk of false negatives in individuals with IgA deficiency. Comprehensive Screening: A holistic evaluation of immune response to gluten. What Do Abnormal Total IgA Levels Mean? Low Total IgA: May indicate IgA deficiency, requiring IgG-based antibody testing to assess for celiac disease. Normal Total IgA: Confirms the reliability of IgA-dependent tests, like tTG IgA and DGP IgA. Why This Matters Celiac disease is often underdiagnosed, partly due to inaccurate testing in individuals with low IgA levels. Measuring Total IgA as part of the 1018 Celiac Profile ensures a thorough and accurate evaluation, enabling proper diagnosis and treatment.
What is Total IgA? Total IgA measures the concentration of Immunoglobulin A in the blood, an antibody that plays a crucial role in immune defense—particularly in the mucous membranes of the respiratory, gastrointestinal, and urogenital tracts. It is the body’s first line of defense against inhaled, ingested, and sexually transmitted pathogens. Why is Total IgA important? IgA provides immune protection by neutralizing viruses and bacteria before they penetrate deeper into the body. It is also involved in maintaining a healthy balance of immune tolerance in the gut. Abnormal IgA levels can signal underlying immune disorders or chronic inflammatory conditions. Low Total IgA may indicate: Selective IgA deficiency – the most common primary immunodeficiency Increased susceptibility to respiratory or gastrointestinal infections Celiac disease, even when asymptomatic Certain autoimmune or inflammatory conditions Protein-losing conditions, such as nephrotic syndrome High Total IgA may indicate: Chronic infections, especially those affecting mucosal surfaces Liver disease, such as cirrhosis Autoimmune diseases, like lupus or rheumatoid arthritis Inflammatory bowel diseases, such as ulcerative colitis or Crohn’s disease Monoclonal gammopathies, like IgA myeloma Who should consider testing Total IgA? This test is useful for individuals with frequent respiratory or digestive infections, unexplained inflammation, or suspected immune deficiency. It is also commonly included in celiac disease screening panels. Clinical note: Since IgA is involved in mucosal immunity, a low level may impair the body’s ability to defend against infections and tolerate harmless antigens, potentially leading to increased inflammation or autoimmunity.
Total IgE antibodies in blood, not mold-specific IgE.